Spoken Alpha
COLGATE PALMOLIVE CO
Colgate-Palmolive manufactures and sells oral care, personal care, and home care products under brands including Colgate, Palmolive, Tom's of Maine, and Irish Spring, as well as specialty pet nutrition products for dogs and cats under the Hill's brand.
COLGATE PALMOLIVE CO is a Consumer Defensive company operating in Household & Personal Products with a $69.61B market cap.
Most recent reported earnings: Q3 FY2026 (Oct 29, 2026).
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CL.
$ curl https://api.spokenalpha.com/v1/companies/CLFAQ
Spoken Alpha indexes CL's earnings call transcripts at https://spokenalpha.com/companies/CL. Each call links to attributed speakers and parsed analyst Q&A. COLGATE PALMOLIVE CO's own investor relations page is at https://investor.colgatepalmolive.com/.
COLGATE PALMOLIVE CO (CL) held its most recent earnings call on 2026-07-31, covering fiscal Q2 2026.
COLGATE PALMOLIVE CO (CL) operates in the Consumer Defensive sector (Household & Personal Products industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-29 | — | $0.92 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-07-30 | $0.99 | $0.95 | +4.2% | $5.36B | — | — | EODHD |
| Q1 FY2026 | 2026-04-30 | $0.97 | $0.94 | +3.2% | $5.32B | — | — | EODHD |
| Q4 FY2025 | 2026-01-29 | $0.95 | $0.91 | +4.4% | $5.23B | — | — | EODHD |
| Q3 FY2025 | 2025-10-30 | $0.91 | $0.89 | +2.3% | $5.13B | — | — | EODHD |
| Q2 FY2025 | 2025-07-31 | $0.92 | $0.89 | +3.4% | $5.11B | — | — | EODHD |
| Q1 FY2025 | 2025-04-24 | $0.91 | $0.86 | +5.8% | $4.91B | — | — | EODHD |
| Q4 FY2024 | 2025-01-30 | $0.91 | $0.89 | +2.3% | $4.94B | — | — | EODHD |
| Q3 FY2024 | 2024-10-24 | $0.91 | $0.88 | +3.4% | $5.03B | — | — | EODHD |
| Q2 FY2024 | 2024-07-25 | $0.91 | $0.87 | +4.6% | $5.06B | — | — | EODHD |
| Q1 FY2024 | 2024-04-25 | $0.86 | $0.81 | +6.2% | $5.07B | — | — | EODHD |
| Q4 FY2023 | 2024-01-25 | $0.87 | $0.85 | +2.4% | $4.95B | — | — | EODHD |
| Q3 FY2023 | 2023-10-26 | $0.86 | $0.80 | +7.5% | $4.92B | — | — | EODHD |
| Q2 FY2023 | 2023-07-27 | $0.77 | $0.75 | +2.7% | $4.82B | — | — | EODHD |
| Q1 FY2023 | 2023-04-27 | $0.73 | $0.70 | +4.3% | $4.77B | — | — | EODHD |
| Q4 FY2022 | 2023-01-26 | $0.77 | $0.77 | 0.0% | $4.63B | — | — | EODHD |
| Q3 FY2022 | 2022-10-27 | $0.74 | $0.73 | +1.4% | $4.46B | — | — | EODHD |
| Q2 FY2022 | 2022-07-28 | $0.72 | $0.71 | +1.4% | $4.48B | — | — | EODHD |
| Q1 FY2022 | 2022-04-28 | $0.74 | $0.75 | -1.3% | $4.40B | — | — | EODHD |
| Q4 FY2021 | 2022-01-27 | $0.79 | $0.79 | 0.0% | $4.40B | — | — | EODHD |
Source: EODHD. CL reported actuals as published; sparse fields render as —.